April 10, 2017
Japanese ophthalmology powerhouse Santen Pharmaceutical said on April 7 that it has made a strategic investment in Regenerative Patch Technologies, a privately held US company developing cell therapy technologies for retinal diseases. According to Santen, the California firm has developed...read more